Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKelso Grp Hldg Regulatory News (KLSO)

Share Price Information for Kelso Grp Hldg (KLSO)

Share Price is delayed by 15 minutes
Get Live Data
2.80    -0.25 (-8.20%)
Bid:
2.80
Ask:
3.30
Spread: 0.50 (17.857%)
Market Cap: £12.99m
KLSO Live PriceLast checked at - London Stock Exchange

Intraday Kelso Grp Hldg Share Chart

Portfolio update

5 Jun 2026 07:00

RNS Number : 1072H
Kelso Group Holdings PLC
05 June 2026
 

5 June 2026

 

Kelso Group Holdings Plc

("Kelso" or the "Company")

Portfolio Update

 

Kelso, the main market listed investment vehicle, is pleased to provide shareholders with the following portfolio update.

 

Portfolio performance

 

Kelso's portfolio has continued to strengthen during May 2026, and as close of business on 29 May 2026 its gross investments stood at approximately £19.4 million, with net assets approximately £14.0 million, equivalent to 3.0 pence per share. This represents an increase of approximately 35% since the start of 2026. Kelso expects first half pre-tax profit including realised and unrealised gains and after operating costs to be in the region of £3.0 million. Approximately one third of this profit is from net gains on realisations in the first five months of the year. The following table sets out the latest portfolio, as at 29 May 2026:

 

TheWorks.co.uk plc ("The Works")

 

Kelso is pleased with the trading statement and guidance upgrade from The Works on 21 May 2026, being the third upgrade to market guidance provided in the last 12 months. Kelso recently increased its holding in The Works to 8% of the issued share capital, with a holding of approximately 5.2 million ordinary shares.

 

NCC Group plc ("NCC")

 

Further to Kelso's update on its investment in NCC on 22 January 2026, Kelso notes that NCC has now completed the sale of its Escode business to TDR Capital LLP for a total enterprise value of £275.0 million, generating estimated net proceeds of approximately £253 million, and has confirmed its intention to return £185 million to shareholders. The method for returning proceeds to shareholders remains subject to the Board decision and will be announced in due course following the Cyber review. Kelso continues to hold 2.1 million ordinary shares in NCC at an average price of 133.7 pence per share, representing approximately 15% of Kelso's gross investments. Kelso remains encouraged by the Board's focus on disciplined capital allocation and continues to believe the remaining Cyber Security business is materially undervalued. Kelso looks forward to NCC's unaudited results for the six months ended 31 March 2026, due to be announced on 11 June 2026.

 

CVS Group plc ("CVS")

 

In addition, Kelso are also pleased with the recent CVS announcement released on 26 May 2026 in relation to their recent acquisitions, successful refinance of its £350m debt facilitates and the launch of a £50 million share buyback program. Kelso has recently increased its holding in CVS from the original position, as announced on 17 February 2026, of 130,000 ordinary shares to approximately 230,000 ordinary shares at an average price of 1,319 pence per share.

 

New investment in Capita plc ("Capita")

 

Over the past few weeks, Kelso has acquired ordinary shares in Capita, a UK-based business process outsourcing and professional services company, with a current market capitalisation of approximately £450 million.

 

Kelso currently holds 400,000 ordinary shares in Capita at an average price of 312 pence per share, with shares currently trading at approximately 368 pence per share. Following the share acquisitions over the last few weeks, Capita now accounts for approximately 8% of our gross investments. Kelso believes that Capita's turnaround strategy is gaining momentum, with Capita now seeing the benefits from simplifying operations, reducing its debt position, and divesting non-core assets. Kelso believes there remains further opportunities for potential disposals which could be value enhancing for shareholders.

 

Filtronic plc ("Filtronic")

 

Kelso has sold its entire Filtronic holding of 500,000 ordinary shares at an average price of 406 pence per share, compared to the average purchase price of 185 pence per share as announced on 27 April 2026, representing a realised gain of approximately 119 per cent.

 

 

Investment

Portfolio Weight

Share price increase since 31 Dec 2025 (or cost price if FY26 addition)

TheWorks.co.uk plc

17%

+82%

NCC Group plc

16%

+4%

CVS Group plc

15%

(5)%

Saga plc

13%

+48%

Capita plc

8%

+27%

Selkirk Group plc

8%

+5%

THG plc

7%

(27)%

Angling Direct plc

6%

(7)%

Other investment 1

5%

+3%

Other investment 2

2%

(2)%

Other investment 3

1%

+39%

 

Approximately 50 per cent of Kelso's gross investments by value are currently held in constituents of the FTSE 250 and the Board estimates that approximately 65% of the portfolio could be liquidated within five trading days.

 

Total Voting Rights

 

Following the recent Placing and Subscription in May 2026, the total number of ordinary shares and voting rights in the Company is 464,069,995.

 

About Kelso

Kelso Group Holdings Plc ("Kelso") is a main market investment vehicle, backed by over 75 investors known to the Board alongside a small number of institutions. The Board own approximately 17 per cent of Kelso and between them have more than 150 years of experience in UK listed companies, across fund management, private equity, corporate finance, law and M&A advisory. Kelso's strategy is to hold a concentrated portfolio of around ten UK companies, each of which it considers to be among the most attractive opportunities in the UK small and mid-cap market. Kelso invests only in established, profitable businesses, predominantly market leaders with strong balance sheets. Kelso does not invest in early stage, speculative or highly cyclical businesses and does not seek resources sector exposure.

Kelso's aim is to generate market leading compounded annual returns for shareholders. The Board is closely aligned with shareholders through its substantial equity ownership. Kelso was established in January 2023 and has raised equity at 2p, 2.5p and subsequently at 3p on three occasions.

For further information please contact:

Kelso Group Holdings plc

+44 (0) 75 4033 3933

John Goold, Chief Executive Officer

Jamie Brooke, Chief Investment Officer

Ian Selby, Chief Financial Officer

Zeus (Financial Adviser and Joint Broker)

+44 (0) 20 3829 5000

Louisa Waddell, John Moran (Investment Banking)Dominic King (Corporate Broking)

Cavendish (Joint Broker)

Stephen Keys, Isaac Hooper

+44 (0) 20 7220 0500

Camarco (Financial PR)

Billy Clegg, Tom Huddart

+44 (0) 20 3757 4980

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUZZGGVMDKGVZZ
12
Date   Source Headline
5th Jun 20267:00 amRNSPortfolio update
28th May 20267:00 amRNSNotice of AGM
22nd May 20267:00 amRNSHolding(s) in Company
14th May 20267:00 amRNSResult of Placing and Subscription
13th May 20267:00 amRNSProposed Placing and Subscription
30th Apr 20267:00 amRNSFY25 Results
27th Apr 20267:00 amRNSNew investment in Filtronic plc
22nd Apr 20265:33 pmRNSHolding(s) in Company
22nd Apr 20265:32 pmRNSHolding(s) in Company
22nd Apr 20265:32 pmRNSHolding(s) in Company
27th Feb 20265:36 pmRNSHolding(s) in Company
23rd Feb 20267:00 amRNSUpdate on Investment: TheWorks.co.uk Plc
20th Feb 20267:00 amRNS-RYellowstone Advisory Presentation
17th Feb 20267:00 amRNSNew investment in CVS Group plc
22nd Jan 20267:00 amRNSUpdate on Investment in NCC Group plc
15th Jan 20269:55 amRNSNotification of Major Holdings
6th Jan 20267:00 amRNSNew investment in Saga plc
17th Dec 20257:00 amRNSResult of Placing and Subscription
16th Dec 20257:00 amRNSUpsizing of Placing and Subscription
15th Dec 20254:35 pmRNSProposed Placing and Subscription
30th Sep 20257:00 amRNSInterim results for six months ended 30 June 2025
25th Jun 20254:17 pmRNSResult of AGM
25th Jun 20257:00 amRNSAGM Trading Update
30th May 20259:06 amRNSNotice of AGM
23rd May 20257:15 amRNSDirector/PDMR Shareholding
16th May 20257:00 amRNSPurchase of Shares & PDMR Shareholding
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSFY24 Results
27th Nov 20247:00 amBUSHolding(s) in Company
7th Nov 20247:00 amRNSOliver Hemsley Appointment & Selkirk IPO Update
17th Oct 20247:00 amRNSUpdate on Kelso Investments
10th Oct 20245:00 pmRNSComment on THG Plc
1st Oct 20248:00 amRNSListing Rule 9.6.14(1) announcement
30th Sep 20247:00 amRNSInterim results for six months ended 30 June 2024
16th Aug 20247:00 amRNSUpdate on Investment in NCC Group Plc
2nd Aug 20247:00 amRNSUpdate on Investment in NCC
7th Jun 20247:00 amRNSNotification of Major Holdings
4th Jun 20247:00 amRNSNotification of Major Holdings
30th May 20244:00 pmRNSResult of AGM
30th May 20247:00 amRNSAGM Trading Update
21st May 20247:00 amRNSVoting intentions at THG AGM
8th May 202411:44 amRNSConfirmation of Accounts and Notice of AGM
8th May 20247:00 amRNSPosting of Annual Report and Notice of AGM
30th Apr 20247:02 amRNSFurther investment in NCC Group Plc
30th Apr 20247:00 amRNSFull-year results for 12 months ended 31 Dec 2023
4th Apr 20248:00 amRNSNotice of Results
14th Mar 20247:00 amRNSNotification of Major Holdings
14th Feb 20247:01 amRNSNED Appointments to The Works
14th Feb 20247:00 amRNSNotification of Major Holdings
30th Jan 20247:00 amRNSNotification of Major Holdings
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.